Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development and Validation of a Blood Test for Early Diagnosis of Colorectal Cancer Based on Molecular Markers and Risk Factors Identified With Artificial Intelligence Tools

NCT06889883 is registered in ClinicalTrials.gov with ADVANCED MARKER DISCOVERY S.L. as lead sponsor.

NCT NCT06889883
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06889883 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development and Validation of a Blood Test for Early Diagnosis of Colorectal Cancer Based on Molecular Markers and Risk Factors Identified With Artificial Intelligence Tools
Lead sponsor
ADVANCED MARKER DISCOVERY S.L.
Phase
Observational
Overall status
Recruiting
Start date
June 6, 2023
Completion date
December 31, 2025
Enrollment
510 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

advanced adenomas (aa), colorectal carcinoma